Luseogliflozin

Chemical formula: C₂₃H₃₀O₆S  Molecular mass: 434.176 g/mol  PubChem compound: 11988953

Active ingredient description

Luseogliflozin lowers plasma glucose by inhibiting the activity of sodium-glucose cotransporter 2 (SGLT2) which is involved in reabsorption of glucose at renal proximal tubules and promoting the excretion of excessive glucose in blood into urine.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A10BK07 A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Discover more medicines within A10BK07

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
LUSEFI Film-coated tablet Web Search MPI, Generic

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 898537-18-3
DrugBank Drug: DB12214
KEGG Drug: D10195
PubChem Compound: 11988953
UNII Identifier: C596HWF74Z
LUSEOGLIFLOZIN

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.